Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 24, Issue 10, Pages 852-860
Publisher
Mary Ann Liebert Inc
Online
2013-09-04
DOI
10.1089/hum.2013.163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- (2013) A. Aiuti et al. SCIENCE
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial
- (2012) Auayporn P. Nademanee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I treat patients who mobilize hematopoietic stem cells poorly
- (2011) L. B. To et al. BLOOD
- Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
- (2011) Evangelia Yannaki et al. MOLECULAR THERAPY
- Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in β-thalassemia
- (2010) Michel Sadelain et al. Annals of the New York Academy of Sciences
- A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study
- (2010) Stefan Fruehauf et al. CYTOTHERAPY
- Gene therapy for β-thalassaemia: the continuing challenge
- (2010) Evangelia Yannaki et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
- (2010) Kaan Boztug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
- (2009) John F. DiPersio et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
- (2009) Alessandro Aiuti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program
- (2008) John P. Miller et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
- (2008) S. M. Devine et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation